1. Home
  2. WKEY vs CING Comparison

WKEY vs CING Comparison

Compare WKEY & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WISeKey International Holding Ltd

WKEY

WISeKey International Holding Ltd

HOLD

Current Price

$7.51

Market Cap

83.5M

Sector

Technology

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$5.26

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKEY
CING
Founded
1999
2012
Country
Switzerland
United States
Employees
102
13
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.5M
93.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WKEY
CING
Price
$7.51
$5.26
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$10.50
$34.50
AVG Volume (30 Days)
90.1K
573.5K
Earning Date
01-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$31.22
N/A
Revenue Next Year
$91.39
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.26
$3.20
52 Week High
$19.80
$11.89

Technical Indicators

Market Signals
Indicator
WKEY
CING
Relative Strength Index (RSI) 61.93 37.13
Support Level $7.26 $3.62
Resistance Level $7.56 $6.85
Average True Range (ATR) 0.47 0.52
MACD 0.15 -0.14
Stochastic Oscillator 94.78 0.00

Price Performance

Historical Comparison
WKEY
CING

About WKEY WISeKey International Holding Ltd

WISeKey International Holding Ltd is a cybersecurity company focused on delivering integrated security solutions for the Internet of Things and digital identity ecosystems. It integrates secure semiconductors, cybersecurity software, and a globally recognized Root of Trust (RoT) into products and services that protect users, devices, data and transactions in the internet-connected world. It has two business segments. The IoT segment, which is the key revenue driver, generates revenue from the sale of semiconductor's secure chips. The mPKI segment generates revenues from Digital Certificates, It derives maximum revenue from IoT segment.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: